Immunodeficiency

3 drugs941 FAERS reportsMedDRA PT

GET

/api/v1/reaction/immunodeficiency

Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D007153

Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.

Source: U.S. National Library of Medicine — MeSH (Immunologic Deficiency Syndromes)

Drugs reporting Immunodeficiency (3)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

1Glucosamine18.3%
2Nortriptyline3726.6%
3Ketoprofen5684.5%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Immunologic Deficiency Syndromes as a MeSH major topic. About the reaction term itself — not about any specific drug.

Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry.
AIDS (London, England) · 2026 · Calcagno A, Strano M, Lolatto R, et al.
PMID 42207142DOI 10.1097/QAD.0000000000004483
Low measles seroprotection among adults with perinatally acquired HIV.
AIDS (London, England) · 2026 · Ryscavage P, Knable C, Taylor G, et al.
PMID 42207140DOI 10.1097/QAD.0000000000004475
HIV Infection: What Is New in Prevention and Treatment?
American family physician · 2026 · Ganesh PR MD, MPH, Navracruz LC MD
PMID 42202359
HIV/AIDS burden, attributable risk factors, and projections among reproductive-age adults in China, 1990-2035: A GBD 2023 analysis.
PloS one · 2026 · Yan H
PMID 42201932DOI 10.1371/journal.pone.0350196
Epidemiology of hepatitis B virus co-infection among people living with HIV in four countries in sub-Saharan Africa.
PloS one · 2026 · Kosgei J, Jaoko W, Oyugi J, et al.
PMID 42201906DOI 10.1371/journal.pone.0337789
Beyond CD4: Posterior segment findings and virologic-immunologic predictors in highly active antiretroviral therapy-naïve HIV patients.
Indian journal of ophthalmology · 2026 · Hayat SC, Yilmaz YC, Gunduz A, et al.
PMID 42200741DOI 10.4103/IJO.IJO_1957_25

What this is

Immunodeficiency is a MedDRA Preferred Term reported on FAERS adverse-event submissions. Each entry below is one drug from the dataset whose FAERS reports mention this reaction.

MeSH descriptor

ID: D007153
Name: Immunologic Deficiency Syndromes
Synonyms: Immunological Deficiency Syndromes, Deficiency Syndrome, Immunological, Deficiency Syndromes, Immunological, Immunological Deficiency Syndrome, Syndrome, Immunological Deficiency, Syndromes, Immunological Deficiency, Immunologic Deficiency Syndrome, Deficiency Syndrome, Immunologic, Syndrome, Immunologic Deficiency, Syndromes, Immunologic Deficiency, Deficiency Syndromes, Immunologic, Antibody Deficiency Syndrome, Deficiency Syndromes, Antibody, Antibody Deficiency Syndromes, Deficiency Syndrome, Antibody, Syndrome, Antibody Deficiency, Syndromes, Antibody Deficiency
Tree: C20.673

Sits under

Immune System Diseases

Full MeSH record

Try the API

cURLbash

curl https://pharmacopeia.dev/api/v1/reaction/immunodeficiency

Source

Source: openFDA · FAERS
Coding: MedDRA Preferred Term
Aliases: —

open.fda.gov/data/faers/

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Immunodeficiency

DefinitionNLM MeSH D007153

Drugs reporting Immunodeficiency (3)

Related reactions

Literature

Search pharmacopeia